United KingdomMHRA drug and device alertsLatest 13 Oct 2026
MHRA medicine and device alerts
The MHRA issued 0 medicine and medical device alerts in the 30 days to 22 Nov 2026, against 2 in the 30 days before; the most frequent since 26 Mar 2026 is the recall (17 of 17). AreaZine's record of this feed began on 26 Mar 2026 and holds 17.
Latest
MHRARecall13 Oct 2026
Continuous renal replacement therapy (CRRT): Consider delayed administration of concurrent echinocandins, such as caspofungin, to reduce the risk of adsorption onto new polyacrylonitrile (PAN)-based f
MHRARecall9 Oct 2026
Nova Biomedical StatStrip ketone test strips: risk of disruption to blood ketone testing due to quality-control failures and supply interruption DSI/2026/013
MHRARecall17 Sep 2026
Radiofrequency (RF) Safety Considerations for Wireless Cardiotocography (CTG) Monitoring Systems (DSI/2026/012)
MHRARecall2 Sep 2026
Filters should be used during the administration of Parenteral Nutrition for patients in all care settings DSI/2026/011
MHRARecall26 Aug 2026
Cobalt-chrome modular neck hip replacements: risk of metal-wear effects and revision surgery (DSI/2026/010)
MHRARecall24 Aug 2026
NGPod pH testing device: quarantine and dispose of all devices (DSI/2026/009)
MHRARecall18 Aug 2026
All rectal catheters (gas and colic relievers): Do not use in infants, including for the treatment of colic, gas-related discomfort or constipation (DSI/2026/008)
MHRARecall17 Aug 2026
National Patient Safety Alert: ResMed Astral 100 and 150 Ventilators: Potential for Patient Harm due to Unexpected Interruption of Ventilation Therapy (NatPSA/2026/004/MHRA)
MHRARecall10 Aug 2026
Devices supplied without valid UKCA/CE conformity markings or certification: remove from use and place in quarantine (DSI/2026/007)
MHRARecall6 Aug 2026
Belzer UW® Cold Storage Solution and Belzer MPS® (UW Machine Perfusion Solution): manufactured by Carnamedica (UKRP: Bridge to Life): Updated advice on the contamination of fluid DSI/2026/006 (update
MHRARecall4 Aug 2026
Dräger Atlan Anaesthesia workstations: risk of ventilator failure (DSI/2026/005)
MHRARecall27 May 2026
Allurion Gastric Balloon: Updated safety information due to the risks of gastric outlet obstruction, small bowel obstruction and gastric perforation (DSI/2026/004)
MHRARecall20 May 2026
Risk of severe harm from use of incorrect giving (administration) set for blood transfusion (DSI/2026/003)
MHRARecall19 May 2026
Kimal Procedure Packs containing recalled components: Namic Angiographic Syringe with the risk of syringe disconnection; Namic Manifolds with the risk of foreign particulates. Important guidance for u
MHRARecall23 Apr 2026
Class 3 Medicines Recall: Omega Pharma Ltd, Napralief 250mg Gastro-Resistant Tablets, EL(26)A/21
MHRARecall30 Mar 2026
Class 2 Medicines Recall: Bio Products Laboratory Limited, Rabies, Human normal Immunoglobulin 500IU solution for Injection, EL(26)A/18
MHRARecall26 Mar 2026
Class 4 Medicines Defect Notification: Sandoz Limited, Apixaban 2.5mg and 5mg Tablets, EL(26)A/17